speb/financial-data huggingface dataset:
HIFS balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 3787000.00
HIFS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 3787000.00
HIFS income_statement (annual, 2024-12-31) — Normalized Income: 28191000.00
HIFS income_statement (annual, 2024-12-31) — Occupancy And Equipment: 1659000.00
HIFS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 11893000.00
HIFS cash_flow (annual, 2024-12-31) — Operating Gains Losses: -20379000.00
HIFS income_statement (annual, 2024-12-31) — Operating Revenue: 65853000.00
HIFS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 2180250.00
HIFS balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 687000000.00
HIFS balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 687000000.00
HIFS income_statement (annual, 2024-12-31) — Other Gand A: 3678000.00
HIFS cash_flow (annual, 2024-12-31) — Other Non Cash Items: -338000.00
HIFS income_statement (annual, 2024-12-31) — Other Non Interest Expense: 3097000.00
HIFS balance_sheet (annual, 2024-12-31) — Other Properties: 5891000.00
HIFS balance_sheet (quarterly, 2024-12-31) — Other Properties: 5891000.00
HIFS balance_sheet (annual, 2024-12-31) — Payables: 8244000.00
HIFS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 8244000.00
HIFS balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
HIFS income_statement (annual, 2024-12-31) — Pretax Income: 36515000.00
HIFS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1266000.00
HIFS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -17204000.00
HIFS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -139000.00
HIFS balance_sheet (annual, 2024-12-31) — Receivables: 8774000.00
HIFS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 750000.00
HIFS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1400675000.00
HIFS balance_sheet (annual, 2024-12-31) — Retained Earnings: 414004000.00
HIFS income_statement (annual, 2024-12-31) — Salaries And Wages: 16910000.00
HIFS cash_flow (annual, 2024-12-31) — Sale Of Investment: 1048000.00
HIFS cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
HIFS cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
HIFS income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 570000.00
HIFS income_statement (annual, 2024-12-31) — Selling General And Administration: 24254000.00
HIFS balance_sheet (annual, 2024-12-31) — Share Issued: 2180250.00
HIFS income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
HIFS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
HIFS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 173000.00
HIFS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 431755000.00
HIFS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 431755000.00
HIFS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
HIFS income_statement (annual, 2024-12-31) — Tax Provision: 8324000.00
HIFS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.23
HIFS balance_sheet (annual, 2024-12-31) — Total Assets: 4457771000.00
HIFS balance_sheet (annual, 2024-12-31) — Total Capitalization: 1241755000.00
HIFS balance_sheet (annual, 2024-12-31) — Total Debt: 1497000000.00
HIFS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 431755000.00
HIFS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 4026016000.00
HIFS income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
HIFS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
HIFS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
HIFS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
HIFS income_statement (quarterly, 2025-03-31) — +Total Revenue: 17585000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 11266000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 9006000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 15622000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 118235000.00
HIFS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 2180000.00
HIFS income_statement (quarterly, 2025-03-31) — Basic EPS: 3.27
HIFS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 351830000.00
HIFS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -30000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2180000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 361641000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 361641000.00
HIFS cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -1374000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 8664000.00
HIFS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 53030000.00
HIFS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -54707000.00
HIFS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 11488000.00
HIFS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 5170000.00
HIFS cash_flow (quarterly, 2025-03-31) — Change In Payable: 5170000.00
HIFS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 5170000.00
HIFS cash_flow (quarterly, 2025-03-31) — Change In Receivables: -277000.00
HIFS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 4893000.00
HIFS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -277000.00
HIFS cash_flow (quarterly, 2025-03-31) — Changes In Cash: 9811000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Common Stock: 2180000.00
HIFS cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -1374000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 437557000.00
HIFS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 282000.00
HIFS cash_flow (quarterly, 2025-03-31) — Deferred Tax: 282000.00
HIFS cash_flow (quarterly, 2025-03-31) — Depreciation: 183000.00
HIFS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 183000.00
HIFS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 183000.00
HIFS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 2201000.00
HIFS income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.24
HIFS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 7124000.00
HIFS cash_flow (quarterly, 2025-03-31) — End Cash Position: 361641000.00
HIFS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 53030000.00
HIFS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 11458000.00
HIFS cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -1281000.00
HIFS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 1281000.00
HIFS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 6161000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 6494000.00
HIFS cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 610000.00
HIFS income_statement (quarterly, 2025-03-31) — Insurance And Claims: 748000.00
HIFS income_statement (quarterly, 2025-03-31) — Interest Expense: 33786000.00
HIFS income_statement (quarterly, 2025-03-31) — Interest Income: 49822000.00
HIFS cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 30764000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1908557000.00
HIFS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -54707000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 124729000.00
HIFS cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 140000000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1471000000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1471000000.00
HIFS cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 140000000.00
HIFS cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -106000000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Net Debt: 1109359000.00
HIFS income_statement (quarterly, 2025-03-31) — Net Income: 7124000.00
HIFS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 7124000.00
HIFS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 7124000.00
HIFS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 7124000.00
HIFS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 7124000.00
HIFS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 7124000.00
HIFS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 7124000.00
HIFS income_statement (quarterly, 2025-03-31) — Net Interest Income: 16036000.00
HIFS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -3611000.00
HIFS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -26000000.00
HIFS cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 34000000.00
HIFS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -879000.00
HIFS cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -300000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Net PPE: 16244000.00
HIFS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -30000.00
HIFS cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -60000000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 437557000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4069000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4069000.00
HIFS income_statement (quarterly, 2025-03-31) — Normalized Income: 7124000.00
HIFS income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 439000.00
HIFS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 11488000.00
HIFS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1281000.00
HIFS income_statement (quarterly, 2025-03-31) — Operating Revenue: 17585000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 2180250.00
HIFS income_statement (quarterly, 2025-03-31) — Other Gand A: 946000.00
HIFS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -84000.00
HIFS income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 734000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Payables: 11266000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 11266000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
HIFS income_statement (quarterly, 2025-03-31) — Pretax Income: 9815000.00
HIFS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
HIFS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -3790000.00
HIFS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -30000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Receivables: 9006000.00
HIFS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 183000.00
HIFS cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -106000000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 419755000.00
HIFS income_statement (quarterly, 2025-03-31) — Salaries And Wages: 4467000.00
HIFS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 179000.00
HIFS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 136000.00
HIFS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 6297000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Share Issued: 2180250.00
HIFS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 51000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 437557000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 437557000.00
HIFS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
HIFS income_statement (quarterly, 2025-03-31) — Tax Provision: 2691000.00
HIFS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
HIFS balance_sheet (quarterly, 2025-03-31) — Total Assets: 4523428000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1908557000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1471000000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 437557000.00
HIFS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4085871000.00
HIFS income_statement (quarterly, 2025-06-30) — +Total Revenue: 20846000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 12959000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 8962000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 15777000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 122689000.00
HIFS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 2181000.00
HIFS income_statement (quarterly, 2025-06-30) — Basic EPS: 4.32
HIFS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 361641000.00
HIFS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -124000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2181000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 360614000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 360614000.00
HIFS cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -1374000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Cash Financial: 8470000.00
HIFS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 6890000.00
HIFS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -13443000.00
HIFS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 5526000.00
HIFS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -1186000.00
HIFS cash_flow (quarterly, 2025-06-30) — Change In Payable: -1186000.00
HIFS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -1186000.00
HIFS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1395000.00
HIFS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -2581000.00
HIFS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -1395000.00
HIFS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1027000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Common Stock: 2181000.00
HIFS cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -1374000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 445752000.00
HIFS cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 560000.00
HIFS cash_flow (quarterly, 2025-06-30) — Deferred Tax: 560000.00
HIFS cash_flow (quarterly, 2025-06-30) — Depreciation: 188000.00
HIFS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 188000.00
HIFS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 188000.00
HIFS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 2200000.00
HIFS income_statement (quarterly, 2025-06-30) — Diluted EPS: 4.28
HIFS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 9414000.00
HIFS cash_flow (quarterly, 2025-06-30) — End Cash Position: 360614000.00
HIFS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 6890000.00
HIFS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 5402000.00
HIFS cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -2516000.00
HIFS income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 2516000.00
HIFS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 6135000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 6494000.00
HIFS cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 6262000.00
HIFS income_statement (quarterly, 2025-06-30) — Insurance And Claims: 784000.00
HIFS income_statement (quarterly, 2025-06-30) — Interest Expense: 33247000.00
HIFS income_statement (quarterly, 2025-06-30) — Interest Income: 51286000.00
HIFS cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 31554000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2017752000.00
HIFS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -13443000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 129183000.00
HIFS cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 251000000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1572000000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1572000000.00
HIFS cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 251000000.00
HIFS cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -185000000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Net Debt: 1211386000.00
HIFS income_statement (quarterly, 2025-06-30) — Net Income: 9414000.00
HIFS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 9414000.00
HIFS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 9414000.00
HIFS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 9414000.00
HIFS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 9414000.00
HIFS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 9414000.00
HIFS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 9414000.00
HIFS income_statement (quarterly, 2025-06-30) — Net Interest Income: 18039000.00
HIFS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -1937000.00
HIFS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 101000000.00
HIFS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 66000000.00
HIFS cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 2658000.00
HIFS cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -3337000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Net PPE: 16180000.00
HIFS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -124000.00
HIFS cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 35000000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 445752000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 4629000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 4629000.00
HIFS income_statement (quarterly, 2025-06-30) — Normalized Income: 9414000.00
HIFS income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 417000.00
HIFS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 5526000.00
HIFS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -2516000.00
HIFS income_statement (quarterly, 2025-06-30) — Operating Revenue: 20846000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 2181250.00
HIFS income_statement (quarterly, 2025-06-30) — Other Gand A: 959000.00
HIFS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -79000.00
HIFS income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 772000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Payables: 12959000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 12959000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
HIFS income_statement (quarterly, 2025-06-30) — Pretax Income: 12850000.00
HIFS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 105000.00
HIFS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1937000.00
HIFS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -124000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Receivables: 8962000.00
HIFS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 188000.00
HIFS cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -185000000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 427794000.00
HIFS income_statement (quarterly, 2025-06-30) — Salaries And Wages: 4392000.00
HIFS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
HIFS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 222000.00
HIFS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 6357000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Share Issued: 2181250.00
HIFS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 51000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 445752000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 445752000.00
HIFS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
HIFS income_statement (quarterly, 2025-06-30) — Tax Provision: 3436000.00
HIFS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.27
HIFS balance_sheet (quarterly, 2025-06-30) — Total Assets: 4539157000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2017752000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Total Debt: 1572000000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 445752000.00
HIFS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4093405000.00
HIFS income_statement (quarterly, 2025-09-30) — +Total Revenue: 30902000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 14652000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 8856000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 15821000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 134110000.00
HIFS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 2181000.00
HIFS income_statement (quarterly, 2025-09-30) — Basic EPS: 7.93
HIFS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 360614000.00
HIFS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -15000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2181000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 360025000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 360025000.00
HIFS cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -1374000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Cash Financial: 6809000.00
HIFS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -30708000.00
HIFS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 18964000.00
HIFS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 11155000.00
HIFS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 2970000.00
HIFS cash_flow (quarterly, 2025-09-30) — Change In Payable: 2970000.00
HIFS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2970000.00
HIFS cash_flow (quarterly, 2025-09-30) — Change In Receivables: -717000.00
HIFS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 2253000.00
HIFS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -717000.00
HIFS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -589000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Common Stock: 2181000.00
HIFS cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -1374000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 461705000.00
HIFS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 2484000.00
HIFS cash_flow (quarterly, 2025-09-30) — Deferred Tax: 2484000.00
HIFS cash_flow (quarterly, 2025-09-30) — Depreciation: 190000.00
HIFS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 190000.00
HIFS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 190000.00
HIFS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 2204000.00
HIFS income_statement (quarterly, 2025-09-30) — Diluted EPS: 7.85
HIFS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 17295000.00
HIFS cash_flow (quarterly, 2025-09-30) — End Cash Position: 360025000.00
HIFS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -30708000.00
HIFS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 11140000.00
HIFS cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -11270000.00
HIFS income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 11270000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -12000.00
HIFS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 6078000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 6494000.00
HIFS cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 3107000.00
HIFS income_statement (quarterly, 2025-09-30) — Insurance And Claims: 698000.00
HIFS income_statement (quarterly, 2025-09-30) — Interest Expense: 33566000.00
HIFS income_statement (quarterly, 2025-09-30) — Interest Income: 52909000.00
HIFS cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 31873000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1987955000.00
HIFS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 18964000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 140604000.00
HIFS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 161250000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1526250000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1526250000.00
HIFS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 161250000.00
HIFS cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -162000000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1166225000.00
HIFS income_statement (quarterly, 2025-09-30) — Net Income: 17295000.00
HIFS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 17295000.00
HIFS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 17295000.00
HIFS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 17295000.00
HIFS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 17295000.00
HIFS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 17295000.00
HIFS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 17295000.00
HIFS income_statement (quarterly, 2025-09-30) — Net Interest Income: 19343000.00
HIFS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -151000.00
HIFS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -45750000.00
HIFS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -750000.00
HIFS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -1661000.00
HIFS cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 1542000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Net PPE: 16005000.00
HIFS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -15000.00
HIFS cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -45000000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 461705000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 7108000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 7108000.00
HIFS income_statement (quarterly, 2025-09-30) — Normalized Income: 17295000.00
HIFS income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 437000.00
HIFS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 11155000.00
HIFS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -11320000.00
HIFS income_statement (quarterly, 2025-09-30) — Operating Revenue: 30902000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 2181250.00
HIFS income_statement (quarterly, 2025-09-30) — Other Gand A: 879000.00
HIFS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -93000.00
HIFS income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 888000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Payables: 14652000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 14652000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
HIFS income_statement (quarterly, 2025-09-30) — Pretax Income: 23115000.00
HIFS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
HIFS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -151000.00
HIFS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -15000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Receivables: 8856000.00
HIFS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 190000.00
HIFS cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -162000000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 443715000.00
HIFS income_statement (quarterly, 2025-09-30) — Salaries And Wages: 4501000.00
HIFS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
HIFS income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 109000.00
HIFS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 6187000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Share Issued: 2181250.00
HIFS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 44000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 461705000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 461705000.00
HIFS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
HIFS income_statement (quarterly, 2025-09-30) — Tax Provision: 5820000.00
HIFS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
HIFS balance_sheet (quarterly, 2025-09-30) — Total Assets: 4531225000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1987955000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1526250000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 461705000.00
HIFS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4069520000.00
HIFS income_statement (annual, 2025-12-31) — +Total Revenue: 104354000.00
HIFS income_statement (quarterly, 2025-12-31) — +Total Revenue: 35021000.00
HIFS balance_sheet (annual, 2025-12-31) — Accounts Payable: 11831000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 11831000.00
HIFS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 9213000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 9213000.00
HIFS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -14236000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -14236000.00
HIFS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 16004000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 16004000.00
HIFS balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 150344000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 150344000.00
HIFS income_statement (annual, 2025-12-31) — Basic Average Shares: 2181000.00
HIFS income_statement (annual, 2025-12-31) — Basic EPS: 25.01
HIFS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 351830000.00
HIFS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 360025000.00
HIFS balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 18309000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 18309000.00
HIFS cash_flow (annual, 2025-12-31) — Capital Expenditure: -266000.00
HIFS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -97000.00
HIFS balance_sheet (annual, 2025-12-31) — Capital Stock: 2182000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2182000.00
HIFS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 369608000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 369608000.00
HIFS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 369608000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 369608000.00
HIFS cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -5496000.00
HIFS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -1374000.00
HIFS balance_sheet (annual, 2025-12-31) — Cash Financial: 6683000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Cash Financial: 6683000.00
HIFS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 19513000.00
HIFS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -9699000.00
HIFS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -37527000.00
HIFS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 11659000.00
HIFS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 35791000.00
HIFS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 7622000.00
HIFS cash_flow (annual, 2025-12-31) — Change In Account Payable: 4928000.00
HIFS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2026000.00
HIFS cash_flow (annual, 2025-12-31) — Change In Payable: 4928000.00
HIFS cash_flow (quarterly, 2025-12-31) — Change In Payable: -2026000.00
HIFS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 4928000.00
HIFS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -2026000.00
HIFS cash_flow (annual, 2025-12-31) — Change In Receivables: -2898000.00
HIFS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -509000.00
HIFS cash_flow (annual, 2025-12-31) — Change In Working Capital: 2030000.00
HIFS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -2535000.00
HIFS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -2898000.00
HIFS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -509000.00
HIFS cash_flow (annual, 2025-12-31) — Changes In Cash: 17778000.00
HIFS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 9583000.00
HIFS balance_sheet (annual, 2025-12-31) — Common Stock: 2182000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Common Stock: 2182000.00
HIFS cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -5496000.00
HIFS cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -1374000.00
HIFS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 479708000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 479708000.00
HIFS balance_sheet (annual, 2025-12-31) — Current Debt: 666565000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Current Debt: 666565000.00
HIFS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 666565000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 666565000.00
HIFS cash_flow (annual, 2025-12-31) — Deferred Income Tax: 5711000.00
HIFS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 2385000.00
HIFS cash_flow (annual, 2025-12-31) — Deferred Tax: 5711000.00
HIFS cash_flow (quarterly, 2025-12-31) — Deferred Tax: 2385000.00
HIFS cash_flow (annual, 2025-12-31) — Depreciation: 752000.00
HIFS cash_flow (quarterly, 2025-12-31) — Depreciation: 191000.00
HIFS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 752000.00
HIFS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 191000.00
HIFS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 752000.00
HIFS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 191000.00
HIFS income_statement (annual, 2025-12-31) — Diluted Average Shares: 2203000.00
HIFS income_statement (annual, 2025-12-31) — Diluted EPS: 24.76
HIFS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 54551000.00
HIFS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 20718000.00
HIFS cash_flow (annual, 2025-12-31) — End Cash Position: 369608000.00
HIFS cash_flow (quarterly, 2025-12-31) — End Cash Position: 369608000.00
HIFS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 19513000.00
HIFS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -9699000.00
HIFS cash_flow (annual, 2025-12-31) — Free Cash Flow: 35526000.00
HIFS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 7526000.00
HIFS cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -28781000.00
HIFS cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -13714000.00
HIFS cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
HIFS income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 28781000.00
HIFS income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 13714000.00
HIFS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -8000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -8000.00
HIFS income_statement (annual, 2025-12-31) — General And Administrative Expense: 24417000.00
HIFS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6043000.00
HIFS balance_sheet (annual, 2025-12-31) — Gross PPE: 30147000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 30147000.00
HIFS balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 7499000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 7499000.00
HIFS cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 12665000.00
HIFS cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 2686000.00
HIFS income_statement (annual, 2025-12-31) — Insurance And Claims: 2844000.00
HIFS income_statement (quarterly, 2025-12-31) — Insurance And Claims: 614000.00
HIFS income_statement (annual, 2025-12-31) — Interest Expense: 132427000.00
HIFS income_statement (quarterly, 2025-12-31) — Interest Expense: 31828000.00
HIFS income_statement (annual, 2025-12-31) — Interest Income: 206833000.00
HIFS income_statement (quarterly, 2025-12-31) — Interest Income: 52816000.00
HIFS cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 128840000.00
HIFS cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 34649000.00
HIFS balance_sheet (annual, 2025-12-31) — Invested Capital: 1943523000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1943523000.00
HIFS cash_flow (annual, 2025-12-31) — Investing Cash Flow: -37527000.00
HIFS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 11659000.00
HIFS balance_sheet (annual, 2025-12-31) — Investments And Advances: 157843000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 157843000.00
HIFS cash_flow (annual, 2025-12-31) — Issuance Of Debt: 685815000.00
HIFS cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 133565000.00
HIFS balance_sheet (annual, 2025-12-31) — Land And Improvements: 4874000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 4874000.00
HIFS balance_sheet (annual, 2025-12-31) — Leases: 921000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Leases: 921000.00
HIFS balance_sheet (annual, 2025-12-31) — Long Term Debt: 797250000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 797250000.00
HIFS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 797250000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 797250000.00
HIFS cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 685815000.00
HIFS cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 133565000.00
HIFS cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -664000000.00
HIFS cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -211000000.00
HIFS balance_sheet (annual, 2025-12-31) — Net Debt: 1094207000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Net Debt: 1094207000.00
HIFS income_statement (annual, 2025-12-31) — Net Income: 54551000.00
HIFS income_statement (quarterly, 2025-12-31) — Net Income: 20718000.00
HIFS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 54551000.00
HIFS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 20718000.00
HIFS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 54551000.00
HIFS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 20718000.00
HIFS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 54551000.00
HIFS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 20718000.00
HIFS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 54551000.00
HIFS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 20718000.00
HIFS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 54551000.00
HIFS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 20718000.00
HIFS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 54551000.00
HIFS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 20718000.00
HIFS income_statement (annual, 2025-12-31) — Net Interest Income: 74406000.00
HIFS income_statement (quarterly, 2025-12-31) — Net Interest Income: 20988000.00
HIFS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -9223000.00
HIFS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -3524000.00
HIFS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -33185000.00
HIFS cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -62435000.00
HIFS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 21815000.00
HIFS cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -77435000.00
HIFS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 1728000.00
HIFS cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 1610000.00
HIFS cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -965000.00
HIFS cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 1130000.00
HIFS balance_sheet (annual, 2025-12-31) — Net PPE: 15911000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Net PPE: 15911000.00
HIFS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -266000.00
HIFS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -97000.00
HIFS cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -55000000.00
HIFS cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 15000000.00
HIFS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 479708000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 479708000.00
HIFS balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 9495000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 9495000.00
HIFS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 9495000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 9495000.00
HIFS income_statement (annual, 2025-12-31) — Normalized Income: 54551000.00
HIFS income_statement (quarterly, 2025-12-31) — Normalized Income: 20718000.00
HIFS income_statement (annual, 2025-12-31) — Occupancy And Equipment: 1745000.00
HIFS income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 452000.00
HIFS cash_flow (annual, 2025-12-31) — Operating Cash Flow: 35792000.00
HIFS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 7623000.00
HIFS cash_flow (annual, 2025-12-31) — Operating Gains Losses: -28831000.00
HIFS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -13714000.00
HIFS income_statement (annual, 2025-12-31) — Operating Revenue: 104354000.00
HIFS income_statement (quarterly, 2025-12-31) — Operating Revenue: 35021000.00
HIFS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 2182250.00
HIFS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 2182250.00
HIFS balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 666565000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 666565000.00
HIFS income_statement (annual, 2025-12-31) — Other Gand A: 3782000.00
HIFS income_statement (quarterly, 2025-12-31) — Other Gand A: 998000.00
HIFS cash_flow (annual, 2025-12-31) — Other Non Cash Items: -337000.00
HIFS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -81000.00
HIFS income_statement (annual, 2025-12-31) — Other Non Interest Expense: 3215000.00
HIFS income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 821000.00
HIFS balance_sheet (annual, 2025-12-31) — Other Properties: 6043000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Other Properties: 6043000.00
HIFS balance_sheet (annual, 2025-12-31) — Payables: 11831000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Payables: 11831000.00
HIFS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 11831000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 11831000.00
HIFS balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
HIFS balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
HIFS income_statement (annual, 2025-12-31) — Pretax Income: 72780000.00
HIFS income_statement (quarterly, 2025-12-31) — Pretax Income: 27000000.00
HIFS cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 244000.00
HIFS cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 139000.00
HIFS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -9402000.00
HIFS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -3524000.00
HIFS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -266000.00
HIFS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -97000.00
HIFS balance_sheet (annual, 2025-12-31) — Receivables: 9213000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Receivables: 9213000.00
HIFS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 752000.00
HIFS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 191000.00
HIFS cash_flow (annual, 2025-12-31) — Repayment Of Debt: -664000000.00
HIFS cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -211000000.00
HIFS balance_sheet (annual, 2025-12-31) — Retained Earnings: 461530000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 461530000.00
HIFS income_statement (annual, 2025-12-31) — Salaries And Wages: 17791000.00
HIFS income_statement (quarterly, 2025-12-31) — Salaries And Wages: 4431000.00
HIFS cash_flow (annual, 2025-12-31) — Sale Of Investment: 179000.00
HIFS cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
HIFS cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
HIFS income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 622000.00
HIFS income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 155000.00
HIFS income_statement (annual, 2025-12-31) — Selling General And Administration: 25039000.00
HIFS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 6198000.00
HIFS balance_sheet (annual, 2025-12-31) — Share Issued: 2182250.00
HIFS balance_sheet (quarterly, 2025-12-31) — Share Issued: 2182250.00
HIFS income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
HIFS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 191000.00
HIFS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 45000.00
HIFS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 479708000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 479708000.00
HIFS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 479708000.00
HIFS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 479708000.00
HIFS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
HIFS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
HIFS income_statement (annual, 2025-12-31) — Tax Provision: 18229000.00